Fig. 1 · Structure
Documents & Downloads
Taltrimide
Anticonvulsive Agent
Taltrimide is a lipophilic derivative of Taurine that functions as an anticonvulsive agent primarily by inhibiting sodium-independent binding of Taurine to synaptic membranes in the brain. This compound demonstrates significant anticonvulsive activity in experimental epilepsy models, while having a lesser impact on GABA binding. Taltrimide is valuable for research aimed at understanding seizure mechanisms and evaluating potential therapeutic interventions for epilepsy.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 81428-04-8 |
| Applications | Anticonvulsive Agent |
| Formula | C13H16N2O4S |
| Molecular Weight | 296.34 |
| Synonyms | MY-117 |
| SMILES | O=S(CCN(C(C1=C2C=CC=C1)=O)C2=O)(NC(C)C)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.